Menu Close

Articles on Therapeutic Goods Administration

Displaying 1 - 20 of 28 articles

The effectiveness of a drug may be evaluated based on its potential to shrink tumours – but this doesn’t necessarily equate to improved survival rates. From shutterstock.com

Do new cancer drugs work? Too often we don’t really know (and neither does your doctor)

National drug regulators use evidence from clinical trials to decide whether new cancer drugs will be approved for use. But these studies are often flawed.
It’s not just women who are the losers following the latest TGA announcement. People with all types of medical devices need better regulatory protection. from www.shutterstock.com

The TGA’s proposed breast implant ban exposes a litany of failures, and fails to protect women

The proposed Australian ban of some types of breast implants is too little, too late. It also reveals regulatory failures that need to be fixed if Australian consumers are to be protected.
Embedded medical devices will continue to be vulnerable to cybersecurity threats. The pacemaker depicted is not made by Abbott’s. REUTERS/Fabrizio Bensch

Three reasons why pacemakers are vulnerable to hacking

Pacemakers are Internet of Things devices for the human body, but they’re still not particularly secure.
The Australian drugs regulator is overhauling the health claims made by suppliers of complementary medicines, including homeopathic therapies. And some curious options are up for discussion. from www.shutterstock.com

New complementary medicine health claims lack evidence, so why are they even on the table?

Would you trust a complementary medicine described as “vermifuge”, “vulnerary” or “emmenagogue”? That’s what new labelling proposes and not everyone’s happy about it.

Top contributors

More